BRPI0514572A - thiazole naphthyl acids - Google Patents
thiazole naphthyl acidsInfo
- Publication number
- BRPI0514572A BRPI0514572A BRPI0514572-4A BRPI0514572A BRPI0514572A BR PI0514572 A BRPI0514572 A BR PI0514572A BR PI0514572 A BRPI0514572 A BR PI0514572A BR PI0514572 A BRPI0514572 A BR PI0514572A
- Authority
- BR
- Brazil
- Prior art keywords
- thiazole
- naphthyl acids
- naphthyl
- acids
- pai
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
CIDOS DE TIAZOLO-NAFTILA. Refere-se aos ácidos de tiazolo-naftila da fórmula (I) métodos de usá-los para modular a expressão de PAI-1 e para tratar distúrbios relacionados a PAI-1. TIAZOLO-NAPHYTLE CIDES The thiazole naphthyl acids of formula (I) refer to methods of using them to modulate PAI-1 expression and to treat PAI-1 related disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60373904P | 2004-08-23 | 2004-08-23 | |
PCT/US2005/029824 WO2006023866A2 (en) | 2004-08-23 | 2005-08-22 | Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0514572A true BRPI0514572A (en) | 2008-06-17 |
Family
ID=35968262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0514572-4A BRPI0514572A (en) | 2004-08-23 | 2005-08-22 | thiazole naphthyl acids |
Country Status (15)
Country | Link |
---|---|
US (2) | US7605172B2 (en) |
EP (1) | EP1794138A2 (en) |
JP (1) | JP2008510816A (en) |
KR (1) | KR20070045353A (en) |
CN (1) | CN101044127A (en) |
AU (1) | AU2005277139A1 (en) |
BR (1) | BRPI0514572A (en) |
CA (1) | CA2577846A1 (en) |
CR (1) | CR8926A (en) |
EC (1) | ECSP077270A (en) |
IL (1) | IL181330A0 (en) |
NO (1) | NO20071378L (en) |
RU (1) | RU2007106869A (en) |
WO (1) | WO2006023866A2 (en) |
ZA (1) | ZA200701583B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004052855A2 (en) * | 2002-12-10 | 2004-06-24 | Wyeth | Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
US7411083B2 (en) * | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
US7265148B2 (en) * | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7141592B2 (en) * | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
US7534894B2 (en) * | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
US7582773B2 (en) * | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
WO2006023864A1 (en) * | 2004-08-23 | 2006-03-02 | Wyeth | Pyrrolo-naphthyl acids as pai-1 inhibitors |
BRPI0614340A2 (en) * | 2005-08-17 | 2011-04-12 | Wyeth Corp | replaced indoles and methods of use |
RU2008128475A (en) * | 2006-02-27 | 2010-04-10 | Вайет (Us) | PAI-1 INHIBITORS FOR TREATING MUSCLE SYSTEM CONDITIONS |
JP2014513686A (en) | 2011-05-10 | 2014-06-05 | メルク・シャープ・アンド・ドーム・コーポレーション | Aminopyrimidines as Syk inhibitors |
EP2707357B1 (en) | 2011-05-10 | 2017-01-18 | Merck Sharp & Dohme Corp. | Pyridyl aminopyridines as syk inhibitors |
EP2706852B1 (en) | 2011-05-10 | 2018-08-22 | Merck Sharp & Dohme Corp. | Bipyridylaminopyridines as syk inhibitors |
JPWO2013018735A1 (en) | 2011-07-29 | 2015-03-05 | 大正製薬株式会社 | Amidine compound or salt thereof |
CN105418527A (en) * | 2015-12-28 | 2016-03-23 | 青岛友诚高新技术有限公司 | Compound with ductal breast cancer prevention activity, and preparation method and use thereof |
CN107162999B (en) * | 2017-06-30 | 2022-06-10 | 淮海工学院 | Synthetic method of 2-phenyl-4-p-hydroxyphenyl thiazole |
Family Cites Families (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3026325A (en) | 1959-01-26 | 1962-03-20 | Upjohn Co | 5-hydroxy-alpha-alkyltryptophans |
US3476770A (en) | 1967-04-14 | 1969-11-04 | Parke Davis & Co | 2-methyl-7-phenylindole-3-acetic acid compounds |
GB1321433A (en) | 1968-01-11 | 1973-06-27 | Roussel Uclaf | 1,2,3,6-tetrasubstituted indoles |
US3557142A (en) | 1968-02-20 | 1971-01-19 | Sterling Drug Inc | 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters |
FR2244499A1 (en) | 1973-06-07 | 1975-04-18 | Delalande Sa | Indol-3-ylformaldoxime carbamates - for treating anxiety epilepsy, cardiac arrhythmias, asthma, intestinal spasm, peptic ulcer, cardiac insufficiency |
DE3147276A1 (en) | 1981-11-28 | 1983-06-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | METHOD FOR THE PRODUCTION OF INDOLDER DERIVATIVES, THE USE THEREOF AS VALUABLE INTERMEDIATE PRODUCTS, AND NEW 4-HYDROXYINDOLS |
FR2525474A1 (en) | 1982-04-26 | 1983-10-28 | Roussel Uclaf | NEW ORAL PHARMACEUTICAL FORM OF CLOMETACIN |
DE3531658A1 (en) | 1985-09-05 | 1987-03-12 | Boehringer Mannheim Gmbh | HETEROCYCLICALLY SUBSTITUTED INDOLE, INTERMEDIATE PRODUCTS, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS |
JPS63139172A (en) | 1986-12-02 | 1988-06-10 | Morishita Seiyaku Kk | 4,5-dihydro-6-(6-substituted-2-naphthyl)-3(2h)-pyridazinone derivative |
US4851423A (en) | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
US5164372A (en) | 1989-04-28 | 1992-11-17 | Fujisawa Pharmaceutical Company, Ltd. | Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same |
WO1991000277A1 (en) | 1989-06-30 | 1991-01-10 | E.I. Du Pont De Nemours And Company | Substituted imidazoles |
IE903206A1 (en) | 1989-09-07 | 1991-03-13 | Abbott Lab | Indole-, benzofuran-, and benzothiophene-containing¹lipoxygenase-inhibiting compounds |
US5420289A (en) | 1989-10-27 | 1995-05-30 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
US5234917A (en) | 1989-12-29 | 1993-08-10 | Finkelstein Joseph A | Substituted 5-(alkyl)carboxamide imidazoles |
CA2037630C (en) | 1990-03-07 | 2001-07-03 | Akira Morimoto | Nitrogen-containing heterocylic compounds, their production and use |
US5196444A (en) | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
DE4035961A1 (en) | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
US5187179A (en) | 1991-03-22 | 1993-02-16 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole |
US5151435A (en) | 1991-04-08 | 1992-09-29 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating an indole or dihydroindole |
US5198438A (en) | 1991-05-07 | 1993-03-30 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
IL101785A0 (en) | 1991-05-10 | 1992-12-30 | Fujisawa Pharmaceutical Co | Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
DE59209008D1 (en) | 1991-08-17 | 1997-12-11 | Hoechst Ag | 2-fluoropyrazines, process for their preparation and their use in liquid-crystalline mixtures |
GB9123396D0 (en) | 1991-11-04 | 1991-12-18 | Hoffmann La Roche | A process for the manufacture of substituted maleimides |
GB9124578D0 (en) | 1991-11-20 | 1992-01-08 | Smithkline Beecham Plc | Chemical compounds |
US5502187A (en) | 1992-04-03 | 1996-03-26 | The Upjohn Company | Pharmaceutically active bicyclic-heterocyclic amines |
US5612360A (en) | 1992-06-03 | 1997-03-18 | Eli Lilly And Company | Angiotensin II antagonists |
GB9213934D0 (en) | 1992-06-30 | 1992-08-12 | Smithkline Beecham Corp | Chemical compounds |
DE4242675A1 (en) | 1992-12-17 | 1994-06-23 | Basf Ag | Hydroxyiminoalkylindolcarboxylic acid derivatives, their preparation and use |
ZA939516B (en) | 1992-12-22 | 1994-06-06 | Smithkline Beecham Corp | Endothelin receptor antagonists |
IL109568A0 (en) | 1993-05-19 | 1994-08-26 | Fujisawa Pharmaceutical Co | Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
US6137002A (en) | 1993-07-22 | 2000-10-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
US6756388B1 (en) | 1993-10-12 | 2004-06-29 | Pfizer Inc. | Benzothiophenes and related compounds as estrogen agonists |
CA2134192A1 (en) | 1993-11-12 | 1995-05-13 | Michael L. Denney | 5, 6-bicyclic glycoprotein iib/iiia antagonists |
DE4338770A1 (en) | 1993-11-12 | 1995-05-18 | Matthias Dr Lehr | Indole-2-alkanoic acids and their derivatives as inhibitors of phospholipase A¶2¶ |
DE4341453A1 (en) | 1993-12-06 | 1995-06-08 | Merck Patent Gmbh | imidazopyridines |
DE4341665A1 (en) | 1993-12-07 | 1995-06-08 | Basf Ag | Bicyclic derivatives, their production and use |
FR2713640B1 (en) | 1993-12-15 | 1996-01-05 | Cird Galderma | New polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses. |
US5521213A (en) | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
US5482960A (en) | 1994-11-14 | 1996-01-09 | Warner-Lambert Company | Nonpeptide endothelin antagonists |
DE69529690T2 (en) | 1994-12-21 | 2003-11-13 | Merck Frosst Canada Inc | DIARYL-2 (5H) -FUARANONE AS COX-2 INHIBITORS |
US5552412A (en) | 1995-01-09 | 1996-09-03 | Pfizer Inc | 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
FR2733684B1 (en) | 1995-05-03 | 1997-05-30 | Cird Galderma | USE OF RETINOIDS IN A COSMETIC COMPOSITION OR FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION |
US5728724A (en) | 1995-08-17 | 1998-03-17 | Eli Lilly And Company | Benzothiophene compounds |
DE19537548A1 (en) | 1995-10-09 | 1997-04-10 | Merck Patent Gmbh | Endothelin receptor antagonists |
DE19543639A1 (en) | 1995-11-23 | 1997-05-28 | Merck Patent Gmbh | Endothelin receptor antagonists |
WO1997048697A1 (en) | 1996-06-19 | 1997-12-24 | Rhone-Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
CA2207083A1 (en) | 1996-07-15 | 1998-01-15 | Brian William Grinnell | Benzothiophene compounds, and uses and formulations thereof |
US5859044A (en) | 1996-07-31 | 1999-01-12 | Pfizer Inc. | β-adrenergic agonists |
DE19753522A1 (en) | 1997-12-03 | 1999-06-10 | Boehringer Ingelheim Pharma | Substituted indoles, their preparation and their use as pharmaceuticals |
FR2777886B1 (en) | 1998-04-27 | 2002-05-31 | Adir | NOVEL BENZOTHIOPHENIC, BENZOFURANIC AND INDOLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US6232322B1 (en) | 1998-05-12 | 2001-05-15 | American Home Products Corporation | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
US6110963A (en) | 1998-05-12 | 2000-08-29 | American Home Products Corporation | Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
US6251936B1 (en) | 1998-05-12 | 2001-06-26 | American Home Products Corporation | Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
US6166069A (en) | 1998-05-12 | 2000-12-26 | American Home Products Corporation | Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
EP1140802B1 (en) | 1998-12-16 | 2004-03-17 | Boehringer Ingelheim Pharma GmbH & Co.KG | Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
AU2319100A (en) | 1999-01-28 | 2000-08-18 | Nippon Shinyaku Co. Ltd. | Amide derivatives and drug compositions |
GB9919413D0 (en) | 1999-08-18 | 1999-10-20 | Zeneca Ltd | Chemical compounds |
FR2799756B1 (en) | 1999-10-15 | 2001-12-14 | Adir | NOVEL BENZOTHIOPHENIC, BENZOFURANIC AND INDOLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
DE19963178A1 (en) | 1999-12-27 | 2001-07-05 | Gruenenthal Gmbh | Substituted indole Mannich bases |
WO2001074793A2 (en) | 2000-04-03 | 2001-10-11 | 3-Dimensional Pharmaceuticals, Inc. | Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1 |
FR2825706B1 (en) | 2001-06-06 | 2003-12-12 | Pf Medicament | NOVEL BENZOTHIENYL OR INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS PRENYL TRANSFERASE PROTEIN INHIBITORS |
TWI224101B (en) * | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
TW591020B (en) * | 2001-06-20 | 2004-06-11 | Wyeth Corp | 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
TWI240723B (en) * | 2001-06-20 | 2005-10-01 | Wyeth Corp | Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
US7291639B2 (en) | 2001-06-20 | 2007-11-06 | Wyeth | Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
ATE367812T1 (en) | 2001-06-20 | 2007-08-15 | Wyeth Corp | SUBSTITUTED INDOLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) |
KR100810468B1 (en) | 2001-10-10 | 2008-03-07 | 씨제이제일제당 (주) | 1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
CN1726191A (en) | 2002-12-10 | 2006-01-25 | 惠氏公司 | Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
WO2004052855A2 (en) | 2002-12-10 | 2004-06-24 | Wyeth | Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
ES2268480T3 (en) | 2002-12-10 | 2007-03-16 | Wyeth | ACID DERIVATIVES 3-RENT- AND 3-ARILALQUILO-1H-INDOL-1-IL-ACETICO REPLACED AS INHIBITORS OF THE INHIBITOR OF THE PLASMINOGEN-1 ACTIVATOR (PAI-1). |
JP2006510673A (en) | 2002-12-10 | 2006-03-30 | ワイス | Aryl, aryloxy and alkyloxy substituted 1H-indol-3-ylglyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor 1 (PAI-1) |
JP4330353B2 (en) | 2003-02-21 | 2009-09-16 | 株式会社静岡カフェイン工業所 | Pyrimidine derivatives |
JP4390460B2 (en) | 2003-02-21 | 2009-12-24 | 株式会社静岡カフェイン工業所 | Oxazole derivatives |
US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
US20050215626A1 (en) | 2003-09-25 | 2005-09-29 | Wyeth | Substituted benzofuran oximes |
US7446201B2 (en) * | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
US7582773B2 (en) | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
US7534894B2 (en) | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
US7163954B2 (en) * | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
US7420083B2 (en) | 2003-09-25 | 2008-09-02 | Wyeth | Substituted aryloximes |
US7141592B2 (en) | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
US7342039B2 (en) | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
KR20070055563A (en) | 2004-08-23 | 2007-05-30 | 와이어쓰 | Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
WO2006023864A1 (en) | 2004-08-23 | 2006-03-02 | Wyeth | Pyrrolo-naphthyl acids as pai-1 inhibitors |
-
2005
- 2005-08-22 RU RU2007106869/04A patent/RU2007106869A/en not_active Application Discontinuation
- 2005-08-22 AU AU2005277139A patent/AU2005277139A1/en not_active Abandoned
- 2005-08-22 CA CA002577846A patent/CA2577846A1/en not_active Abandoned
- 2005-08-22 WO PCT/US2005/029824 patent/WO2006023866A2/en active Application Filing
- 2005-08-22 JP JP2007530023A patent/JP2008510816A/en not_active Withdrawn
- 2005-08-22 CN CNA2005800355900A patent/CN101044127A/en active Pending
- 2005-08-22 BR BRPI0514572-4A patent/BRPI0514572A/en not_active IP Right Cessation
- 2005-08-22 US US11/208,772 patent/US7605172B2/en not_active Expired - Fee Related
- 2005-08-22 EP EP05792721A patent/EP1794138A2/en not_active Withdrawn
- 2005-08-22 KR KR1020077006735A patent/KR20070045353A/en not_active Application Discontinuation
-
2007
- 2007-02-14 IL IL181330A patent/IL181330A0/en unknown
- 2007-02-15 CR CR8926A patent/CR8926A/en not_active Application Discontinuation
- 2007-02-22 ZA ZA200701583A patent/ZA200701583B/en unknown
- 2007-02-23 EC EC2007007270A patent/ECSP077270A/en unknown
- 2007-03-14 NO NO20071378A patent/NO20071378L/en not_active Application Discontinuation
-
2009
- 2009-09-04 US US12/554,131 patent/US20090326021A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2006023866A3 (en) | 2006-06-01 |
WO2006023866A2 (en) | 2006-03-02 |
CN101044127A (en) | 2007-09-26 |
ZA200701583B (en) | 2009-08-26 |
ECSP077270A (en) | 2007-03-29 |
US20090326021A1 (en) | 2009-12-31 |
AU2005277139A1 (en) | 2006-03-02 |
CA2577846A1 (en) | 2006-03-02 |
JP2008510816A (en) | 2008-04-10 |
US7605172B2 (en) | 2009-10-20 |
US20060052420A1 (en) | 2006-03-09 |
NO20071378L (en) | 2007-03-23 |
CR8926A (en) | 2007-08-28 |
IL181330A0 (en) | 2007-07-04 |
RU2007106869A (en) | 2008-09-27 |
KR20070045353A (en) | 2007-05-02 |
EP1794138A2 (en) | 2007-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0514572A (en) | thiazole naphthyl acids | |
BRPI0514544A (en) | oxazol-naphthyl acids as modulators of plasminogen activator inhibitor type-1 (pai-1) | |
PA8580501A1 (en) | DERIVATIVES OF INDOL OR DERIVATIVES OF BENCIMIDAZOL TO MODULATE IKB QUINASA | |
PH12020551578A1 (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
UY38685A (en) | INTEGRATED TRACK MODULATORS | |
SV2009003299A (en) | USED DIHYDROPIRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN QUINASE | |
RS53599B1 (en) | Pyridone derivatives for modulating stress-activated protein kinase system | |
CR20110016A (en) | CHEMICAL COMPOUNDS 251 | |
UY27749A1 (en) | COMPOUNDS THAT MODULATE PPAR ACTIVITY AND PROCEDURES FOR PREPARATION | |
EA200870193A1 (en) | CYTOTOXIC AGENTS, INCLUDING NEW TOMAMYCIN DERIVATIVES, AND THEIR THERAPEUTIC APPLICATION | |
DK1206474T3 (en) | Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors | |
GT200900264A (en) | MOLECULES AND METHODS TO MODULATE PRO-PROTEIN | |
UY27362A1 (en) | METHODS OF USING SOLUBLE HYDROLASE EPOXIDE INHIBITORS | |
ATE369333T1 (en) | SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES | |
ATE375977T1 (en) | SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES | |
NO20084334L (en) | Pharmaceutical compositions | |
ECSP088440A (en) | IMIDAZOPIRAZINS AS INHIBITORS OF PROTEINQUINASA | |
TW200607491A (en) | Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders | |
UY30846A1 (en) | OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES | |
DE602006013191D1 (en) | SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXYLIC ACIDS ARE EFFECTIVE PARP INHIBITORS | |
AR067903A1 (en) | METHOD TO TREAT STRESSED DEPRESSION | |
BRPI0519070A2 (en) | lyophilized keratinocyte growth factor composition, methods for preparing a lyophilized keratinocyte growth factor, and for treating a disease, and kit for preparing an aqueous pharmaceutical composition | |
DE602006003094D1 (en) | 4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROCHINOLINE DERIVATIVES FOR THE TREATMENT OF BARRENESS | |
UY29741A1 (en) | SALTS OF 1,5- DIARIL PIRAZOL-3-CARBOXAMIDS, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, APPLICATIONS AND METHODS OF USE. | |
NO20080133L (en) | Azolopyridin-2-one derivatives such as lipase and phospholipase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |